Nephros EBITDA vs. Shares Owned By Insiders
| NEPH Stock | USD 1.55 0.04 2.65% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -1.4 M | Current Value -1.4 M | Quarterly Volatility 975.7 K |
For Nephros profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Nephros to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Nephros utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Nephros's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Nephros over time as well as its relative position and ranking within its peers.
Nephros |
Is Household Appliances space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.09) | Revenue Per Share 1.313 | Quarterly Revenue Growth (0.08) | Return On Assets (0.08) | Return On Equity (0.16) |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Nephros Shares Owned By Insiders vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Nephros's current stock value. Our valuation model uses many indicators to compare Nephros value to that of its competitors to determine the firm's financial worth. Nephros is considered to be number one stock in ebitda category among its peers. It also is considered to be number one stock in shares owned by insiders category among its peers . As of now, Nephros' EBITDA is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nephros' earnings, one of the primary drivers of an investment's value.Nephros Shares Owned By Insiders vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Nephros |
| = | (1.38 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Nephros |
| = | 12.70 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Nephros Shares Owned By Insiders Comparison
Nephros is currently under evaluation in shares owned by insiders category among its peers.
Nephros Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Nephros, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Nephros will eventually generate negative long term returns. The profitability progress is the general direction of Nephros' change in net profit over the period of time. It can combine multiple indicators of Nephros, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -1.6 M | -1.7 M | |
| Net Loss | -1.6 M | -1.7 M | |
| Income Tax Expense | 46.1 K | 43.8 K | |
| Income Before Tax | -1.6 M | -1.7 M | |
| Total Other Income Expense Net | 18 K | 18.9 K | |
| Net Loss | -1.6 M | -1.7 M | |
| Non Operating Income Net Other | -162.2 K | -170.3 K | |
| Net Loss | -6.6 M | -6.3 M | |
| Interest Income | 43 K | 40.9 K | |
| Net Interest Income | 39 K | 41 K | |
| Change To Netincome | 1.4 M | 1 M | |
| Net Loss | (0.15) | (0.16) | |
| Income Quality | (0.53) | (0.50) | |
| Net Income Per E B T | 1.54 | 0.92 |
Nephros Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Nephros. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Nephros position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Nephros' important profitability drivers and their relationship over time.
Use Nephros in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nephros position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nephros will appreciate offsetting losses from the drop in the long position's value.Nephros Pair Trading
Nephros Pair Trading Analysis
The ability to find closely correlated positions to Nephros could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nephros when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nephros - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nephros to buy it.
The correlation of Nephros is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nephros moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nephros moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nephros can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Nephros position
In addition to having Nephros in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Diversified Assets Thematic Idea Now
Diversified Assets
Pablicly traded close-end funds and other entities backed by different types of diversified investments. The Diversified Assets theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Diversified Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
To fully project Nephros' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Nephros at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Nephros' income statement, its balance sheet, and the statement of cash flows.